Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic acid in patients undergoing coronary artery bypass grafting
IRCT20200825048515N75Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ascorbic acid in coronary arteriosclerosis, sponsored by Isfahan University of Medical Sciences. Started Dec 2024; status: completed.
02
Drugs
ascorbic acid
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20200825048515N75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N75.